Litcius/Paper detail

MA07.09 BBT-176, a 4th generation EGFR TKI, for Progressed NSCLC after EGFR TKI Therapy: PK, Safety and Efficacy from Phase 1 Study

S.M. Lim, J.S. Ahn, M.-H. Hong, T.M. Kim, H.-A. Jung, H.-A. Jung, S.-H.I. Ou, S. Jeong, Y.-H. Lee, E. K. Yim, S. Jung, S.-Y. Lee, D.-W. Kim

2022Journal of Thoracic Oncology16 citationsDOI

Topics & Concepts

MedicineOncologyInternal medicineLung Cancer Treatments and MutationsRadiopharmaceutical Chemistry and ApplicationsCancer therapeutics and mechanisms
MA07.09 BBT-176, a 4th generation EGFR TKI, for Progressed NSCLC after EGFR TKI Therapy: PK, Safety and Efficacy from Phase 1 Study | Litcius